The Nifty Pharma index slipped sharply by over 2% in the intra-day trading session, extending the benchmark’s losing streak to five consecutive sessions. A quick look at the list of pharma sector stocks indicate that all the 20 constituents are trading in red today.

This decline in share price of Pharma stocks comes in response to US President Donald Trump’s announcement of a 100% tariff on branded pharmaceutical imports, a move that raised investor concerns across Dalal Street.

However, from the Indian perspective, most analysts indicate that the long-term impact for Indian companies could be limited and need to be analysed further as the tariffs are primarily on branded drugs. A significant portion of the Indian exports to US are generics. Indian exports cater to nearly 40% of th

See Full Page